These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20238309)

  • 1. Anthelmintics for people with neurocysticercosis.
    Abba K; Ramaratnam S; Ranganathan LN
    Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD000215. PubMed ID: 20238309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthelmintics for people with neurocysticercosis.
    Abba K; Ramaratnam S; Ranganathan LN
    Cochrane Database Syst Rev; 2010 Jan; (1):CD000215. PubMed ID: 20091504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthelmintics for people with neurocysticercosis.
    Monk EJM; Abba K; Ranganathan LN
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD000215. PubMed ID: 34060667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WITHDRAWN: Drugs for treating neurocysticercosis (tapeworm infection of the brain).
    Salinas R; Prasad K
    Cochrane Database Syst Rev; 2007 Jul; (4):CD000215. PubMed ID: 17636621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs for treating neurocysticercosis (tapeworm infection of the brain).
    Salinas R; Prasad K
    Cochrane Database Syst Rev; 2000; (2):CD000215. PubMed ID: 10796510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating neurocysticercosis medically: a systematic review of randomized, controlled trials.
    Salinas R; Counsell C; Prasad K; Gelband H; Garner P
    Trop Med Int Health; 1999 Nov; 4(11):713-8. PubMed ID: 10588764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroids for neurocysticercosis: a systematic review and meta-analysis of randomized controlled trials.
    Cuello-García CA; Roldán-Benítez YM; Pérez-Gaxiola G; Villarreal-Careaga J
    Int J Infect Dis; 2013 Aug; 17(8):e583-92. PubMed ID: 23339852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthelmintic drugs for treating ascariasis.
    Conterno LO; Turchi MD; Corrêa I; Monteiro de Barros Almeida RA
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010599. PubMed ID: 32289194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiepileptic drugs for seizure control in people with neurocysticercosis.
    Walton D; Castell H; Collie C; Wood GK; Sharma M; Singh T; Michael BD
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD009027. PubMed ID: 34723391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs for treating urinary schistosomiasis.
    Kramer CV; Zhang F; Sinclair D; Olliaro PL
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD000053. PubMed ID: 25099517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiepileptic drugs for seizure control in people with neurocysticercosis.
    Sharma M; Singh T; Mathew A
    Cochrane Database Syst Rev; 2015 Oct; (10):CD009027. PubMed ID: 26455722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis.
    Garcia HH; Lescano AG; Gonzales I; Bustos JA; Pretell EJ; Horton J; Saavedra H; Gonzalez AE; Gilman RH;
    Clin Infect Dis; 2016 Jun; 62(11):1375-9. PubMed ID: 26984901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis.
    Macfarlane CL; Budhathoki SS; Johnson S; Richardson M; Garner P
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD003753. PubMed ID: 30620051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials.
    Matthaiou DK; Panos G; Adamidi ES; Falagas ME
    PLoS Negl Trop Dis; 2008 Mar; 2(3):e194. PubMed ID: 18335068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis.
    Singhi P; Jain V; Khandelwal N
    J Child Neurol; 2004 May; 19(5):323-7. PubMed ID: 15224704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
    Del Brutto OH; Roos KL; Coffey CS; García HH
    Ann Intern Med; 2006 Jul; 145(1):43-51. PubMed ID: 16818928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection.
    Henriquez-Camacho C; Gotuzzo E; Echevarria J; White AC; Terashima A; Samalvides F; Pérez-Molina JA; Plana MN
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD007745. PubMed ID: 26778150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs for treating urinary schistosomiasis.
    Danso-Appiah A; Utzinger J; Liu J; Olliaro P
    Cochrane Database Syst Rev; 2008 Jul; (3):CD000053. PubMed ID: 18646057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.
    Garcia HH; Gonzales I; Lescano AG; Bustos JA; Zimic M; Escalante D; Saavedra H; Gavidia M; Rodriguez L; Najar E; Umeres H; Pretell EJ;
    Lancet Infect Dis; 2014 Aug; 14(8):687-695. PubMed ID: 24999157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.